WSA Reports 1% Organic Growth and Improved Profitability in Q2 FY 2025/26

wsa
HHTM
May 13, 2026

LYNGE, DENMARK — WS Audiology (WSA) reported 1% organic revenue growth and improved profitability during the second quarter of fiscal year 2025/26, while maintaining its outlook for the full financial year.

The company reported second-quarter revenue of EUR 628 million (~$712 million USD), representing 1% organic growth year-over-year, though reported revenue declined 6% due primarily to currency headwinds.

EBITDA before special items remained at EUR 117 million (~$133 million USD), while EBITDA margin before special items improved by 1.1 percentage points to 18.6%.

According to WSA, the profitability improvement was driven by operational efficiency gains and cost reductions implemented during FY 2024/25.

“Our organic revenue growth in the second quarter was in line with expectations, and we are continuously improving our profitability. It is encouraging that we are continuing to experience solid momentum in our Online and Retail channels, as well as strong performance in Managed Care. Today, we are launching the Signia Active Mini IX, the world’s smallest ready-to-wear hearing aid with the full power of the IX platform. We look forward to launching more breakthrough innovations on our Widex and Signia platforms soon.”

–Jan Mäkelä, CEO of WSA

Consumer Channels Continue to Drive Growth

WSA said its consumer-facing business delivered 9% organic growth during the quarter, supported by strong performance in Online and Managed Care channels, along with continued growth in Retail.

By comparison, the wholesale business declined 6% organically, which the company attributed primarily to the timing of product launches.

Regional performance varied during the quarter, with the Americas reporting 4% organic growth, while EMEA declined 3% and APAC remained flat.

Signia Active Mini IX and Sound Preference Research

Alongside its quarterly results, WSA announced the launch of the Signia Active Mini IX, which the company describes as the world’s smallest ready-to-wear in-the-ear hearing aid featuring connectivity, rechargeability, and the full IX platform.

WSA also stated that additional product launches on both the Widex and Signia platforms are expected in the near future.

The company additionally highlighted its recently announced “Sound Preference” research initiative, which explores personalized sound processing preferences among listeners.

According to WSA, research conducted by the company found that up to 40% of listeners demonstrate a strong and consistent preference for one sound processing philosophy over another.

First Half Results and Outlook

For the first six months of FY 2025/26, WSA reported revenue of EUR 1.257 billion ($1.43 billion USD), with flat organic growth year-over-year. Reported revenue declined 6% due to currency headwinds.

EBITDA before special items for the first half totaled EUR 228 million ($259 million USD), a decline of EUR 3 million ($3.4 million USD) compared to the prior year, though margin improved by 0.8 percentage points.

WSA maintained its full-year FY 2025/26 outlook, projecting organic revenue growth between 0% and 4%.

The company said the guidance reflects continued support from its product portfolio and upcoming launches, while also acknowledging ongoing macroeconomic uncertainty.

WSA also expects EBITDA margin before special items to improve by approximately 1 percentage point compared to FY 2024/25.

For the full Q2 FY 2025/26 financial report, visit WSA.com/investors/reports.

 

Source: WSA

Email Marketing by Benchmark